Cargando…
Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus
3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832947/ https://www.ncbi.nlm.nih.gov/pubmed/33520632 http://dx.doi.org/10.1016/j.rechem.2020.100087 |
_version_ | 1783641949253664768 |
---|---|
author | Hartini, Yustina Saputra, Bakti Wahono, Bryan Auw, Zerlinda Indayani, Friska Adelya, Lintang Namba, Gabriel Hariono, Maywan |
author_facet | Hartini, Yustina Saputra, Bakti Wahono, Bryan Auw, Zerlinda Indayani, Friska Adelya, Lintang Namba, Gabriel Hariono, Maywan |
author_sort | Hartini, Yustina |
collection | PubMed |
description | 3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targeted in the previous SARS-Coronavirus including bat and MERS, hence, by blocking this protein activity, the coronavirus should be eradicated. This study aims to review the potency of biflavonoid as the SARS-Coronavirus-2 3CLpro inhibitor. The review was initiated by describing the chemical structure of biflavonoid and followed by listing its natural source. Instead, the synthetic pathway of biflavonoid was also elaborated. The 3CLpro structure and its function were also illustrated followed by the list of its 3D-crystal structure available in a protein data bank. Lastly, the pharmacophores of biflavonoid have been identified as a protease inhibitor, was also discussed. This review hopefully will help researchers to obtain packed information about biflavonoid which could lead to the study in designing and discovering a novel SARS-Coronavirus-2 drug by targetting the 3CLpro enzyme. |
format | Online Article Text |
id | pubmed-7832947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78329472021-01-26 Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus Hartini, Yustina Saputra, Bakti Wahono, Bryan Auw, Zerlinda Indayani, Friska Adelya, Lintang Namba, Gabriel Hariono, Maywan Results Chem Article 3CL protease is one of the key proteins expressed by SARS-Coronavirus-2 cell, the potential to be targeted in the discovery of antivirus during this COVID-19 pandemic. This protein regulates the proteolysis of viral polypeptide essential in forming RNA virus. 3CL protease (3CLpro) was commonly targeted in the previous SARS-Coronavirus including bat and MERS, hence, by blocking this protein activity, the coronavirus should be eradicated. This study aims to review the potency of biflavonoid as the SARS-Coronavirus-2 3CLpro inhibitor. The review was initiated by describing the chemical structure of biflavonoid and followed by listing its natural source. Instead, the synthetic pathway of biflavonoid was also elaborated. The 3CLpro structure and its function were also illustrated followed by the list of its 3D-crystal structure available in a protein data bank. Lastly, the pharmacophores of biflavonoid have been identified as a protease inhibitor, was also discussed. This review hopefully will help researchers to obtain packed information about biflavonoid which could lead to the study in designing and discovering a novel SARS-Coronavirus-2 drug by targetting the 3CLpro enzyme. The Author(s). Published by Elsevier B.V. 2021-01 2020-12-25 /pmc/articles/PMC7832947/ /pubmed/33520632 http://dx.doi.org/10.1016/j.rechem.2020.100087 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Hartini, Yustina Saputra, Bakti Wahono, Bryan Auw, Zerlinda Indayani, Friska Adelya, Lintang Namba, Gabriel Hariono, Maywan Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title | Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title_full | Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title_fullStr | Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title_full_unstemmed | Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title_short | Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus |
title_sort | biflavonoid as potential 3-chymotrypsin-like protease (3clpro) inhibitor of sars-coronavirus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832947/ https://www.ncbi.nlm.nih.gov/pubmed/33520632 http://dx.doi.org/10.1016/j.rechem.2020.100087 |
work_keys_str_mv | AT hartiniyustina biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT saputrabakti biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT wahonobryan biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT auwzerlinda biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT indayanifriska biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT adelyalintang biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT nambagabriel biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus AT harionomaywan biflavonoidaspotential3chymotrypsinlikeprotease3clproinhibitorofsarscoronavirus |